2010-11-10 00:00:00,Johnson Unit Janssen Pharmaceutica Together with Eight Other Companies to Collaborate on Data Share on Psychiatric
2010-11-24 00:00:00,Johnson Johnson Recalls More Cites Label
2010-11-29 00:00:00,Tribunal Finds Johnson Johnson In Breach Of License Agreement With Basilea Pharmaceutica AG
2010-12-06 00:00:00,Lawsuits Against Johnson Johnson Involving Defective DePuy Hip Replacement Parts To Be consolidated In Multidistrict Litigation
2011-01-05 00:00:00,Bayer Johnson Johnson Ask For Approval For Main Use Of
2011-02-18 00:00:00,Johnson Johnson Recalls Two Lots Of Simponi Injection
2011-02-22 00:00:00,Johnson Johnson Completes Tender Offer For Crucell And Declares Offer Unconditional
2011-02-24 00:00:00,Abbott Boston Scientific Corporations Boston Scientific Ceska Johnson Medtronic Czechia and Others Win Daily News
2011-03-08 00:00:00,Johnson Johnson Acquires Of Issued Crucell Shares
2011-03-09 00:00:00,Johnson Johnson Recalls Leaky Insulin
2011-03-11 00:00:00,FDA To Oversee Johnson Johnson Plants After Flood Of
2011-03-14 00:00:00,Eli Lilly and Elanco Announces Offer To Acquire Janssen Pharmaceutica Janssen Animal Health Business
2011-03-23 00:00:00,POZEN Announces Licensing Deal with Johnson Cilag GmbH for MT Migraine Treatment
2011-03-29 00:00:00,Johnson Johnson Issues More Drug
2011-03-31 00:00:00,Johnson Johnson Reorganizes Consumer Group In Wake Of
2011-04-05 00:00:00,Higher Bleeding Risk Seen In Johnson Johnson And Bayer AG Clot
2011-04-14 00:00:00,Johnson Johnson Recalls Bottles Of Epilepsy
2011-04-28 00:00:00,Johnson Johnson Announces Dividend Increase Of
2011-04-29 00:00:00,Johnson Centocor Ortho Biotech Products LP Informs to Zeltia Pharma Mar SA Its Decision to Withdraw the NDA for Yondelis in Combination With Doxil
2011-05-20 00:00:00,US FDA Approves New Johnson Johnson HIV
2011-05-23 00:00:00,Johnson Johnson Acquires Russian OTC Medicines For
2011-05-24 00:00:00,JB Chemicals Pharmaceuticals Limited To Sell Business And Worldwide Rights And Registrations Of Three OTC Brands To Johnson Cilag GmbH International
2011-05-26 00:00:00,Johnson Johnson To Seek Approval For 11 New Drugs By
2011-06-01 00:00:00,Johnson Terminates Agreement with Diamyd Medical AB Concerning Diabetes Therapy
2011-06-14 00:00:00,Johnson Johnson Wins Approval For Hip Replacement
2011-06-15 00:00:00,Johnson Johnson To Quit Struggling Heart Stent
2011-06-16 00:00:00,Johnson Johnson To Exit Stent To CLose Two Announces
2011-06-24 00:00:00,US FDA urges caution on And Johnson Johnson Anemia
2011-07-01 00:00:00,US Regulators Approve Bayer AG And Johnson Blood
2011-07-07 00:00:00,Johnson Johnson Announces Global Sponsorship Of 2014 FIFA World Cup Brazil
2011-07-18 00:00:00,Johnson Johnson Announces Third Quarter 2011 Quarterly Dividend
2011-09-08 00:00:00,Johnson Johnson Announces FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban For Prevention Of Stroke Systemic Embolism In Patients With Non Valvular Atrial Fibrillation
2011-09-14 00:00:00,Johnson Johnson Pleads Guilty In Natrecor Marketing
2011-09-23 00:00:00,Bayer AG And Johnson Xarelto Recommended for Approval in the Prevention of AF Related Stroke and Treatment of Deep Vein Thrombosis in EU
2011-10-18 00:00:00,Johnson Johnson Raises Low End Of Prior FY 2011 EPS Guidance To A Range In Line With Estimates
2011-10-21 00:00:00,Johnson Johnson Announces Fourth Quarter 2011 Quarterly Dividend
2011-11-09 00:00:00,Affymax Inc and Johnson Janssen Biotech Settles Patent Dispute
2011-12-08 00:00:00,Johnson Janssen Initiates Phase II Clinical Trial with CNTO 1959 with MorhoSys AG
2011-12-12 00:00:00,Symmetry Medical To Acquire Surgical Instruments Business of Codman Shurtleff A Johnson Johnson Company
2012-01-18 00:00:00,FDA Warns Johnson DePuy Unit Over Joint
2012-01-23 00:00:00,Federal Court Rules In Favor Of Boston Scientific in Johnson Johnson
2012-02-21 00:00:00,Alex Gorsky To Succeed Bill Weldon As CEO Of Johnson Johnson
2012-03-26 00:00:00,Johnson Janssen Research LLC Announces XARELTO Demonstrates Comparable Efficacy To Standard of Care For Treatment Secondary Prevention Of Venous Blood Clots
2012-04-11 00:00:00,Johnson Johnson Hit With Billion Risperdal Penalty In
2012-04-26 00:00:00,Johnson Johnson Announces Dividend Increase Of
2012-06-20 00:00:00,Johnson Johnson Close To Settling With DOJ Over
2012-06-21 00:00:00,US FDA Rejects Wider Use For Johnson And Bayer
2012-07-16 00:00:00,Johnson Johnson Announces Quarterly Dividend For Third Quarter 2012
2012-07-24 00:00:00,Pfizer Johnson Johnson Drug Fails One Of Four Big Reuters
2012-08-21 00:00:00,Johnson Unit Recalls Bone
2012-08-30 00:00:00,Johnson Janssen Announces Global License And Development Agreement For Investigational Agent Daratumumab With Genmab
2012-09-04 00:00:00,Johnson Johnson Announces Indirect Stake in Galapagos NV
2012-10-23 00:00:00,Johnson Litigation Makes This Pharma A Pass In 2013
2012-11-01 00:00:00,Johnson Johnson Is En Route To
2012-11-08 00:00:00,JOHNSON JOHNSON Janssen and Johnson Johnson to Provide Webcast
